Adenine Sulfate Improves Cardiac Function and the Cardiac Cholinergic System After Myocardial Infarction in Rats
-
- Sun Lei
- Department of Pharmacology, School of Life Science and Technology, Xi’an Jiaotong University, China
-
- Lu Jun
- Department of Pharmacology, School of Life Science and Technology, Xi’an Jiaotong University, China
-
- Yu Xiao-Jiang
- Department of Pharmacology, School of Life Science and Technology, Xi’an Jiaotong University, China
-
- Li Dong-Ling
- Department of Pharmacology, School of Life Science and Technology, Xi’an Jiaotong University, China
-
- Xu Xiao-Li
- Department of Pharmacology, School of Life Science and Technology, Xi’an Jiaotong University, China
-
- Wang Bing
- Department of Pathology, College of Medicine, School of Life Science and Technology, Xi’an Jiaotong University, China
-
- Ren Ke-Yu
- Department of Pharmacology, School of Life Science and Technology, Xi’an Jiaotong University, China
-
- Liu Jian-Kang
- Institute of Mitochondrial Biology & Medicine, School of Life Science and Technology, Xi’an Jiaotong University, China
-
- Zang Wei-Jin
- Department of Pharmacology, School of Life Science and Technology, Xi’an Jiaotong University, China
この論文をさがす
抄録
Recent studies have shown that vagal activation may have an important therapeutic implication for myocardial infarction (MI), but effective strategies remain unexplored. Here, we investigate whether adenine sulfate can preserve cardiac function and the cholinergic system against MI. Rats were treated with adenine sulfate for three weeks after coronary ligation. Cardiac function was assessed by hemodynamics. The muscarinic M2 receptor and cholinesterase-positive nerves were semi-quantified by immunochemical and histochemical staining. The maximal binding capacity (Bmax) of muscarinic receptors, determined by radioligand binding assay, showed that cardiac function was impaired in MI rats. Adenine sulfate reversed MI-induced reduction of mean artery pressure and left ventricular systolic pressure and elevation of left ventricular end-diastolic pressure. Moreover, adenine sulfate also increased nitric oxide (NO) and nitric oxide synthase (NOS) activity. The amelioration was accompanied by a reversal of the infarction-induced reduction of cholinesterase-positive nerves and M2-receptor expression and Bmax in the adenine sulfate high dose group. Meanwhile, adenine sulfate treatment corrected the disorder of cardiac redox state by reduction in maleic dialdehyde and increase in superoxide dismutase. In conclusion, adenine sulfate exerts cardioprotection against MI and ameliorates NO production. Changes in cardiac vagal distribution density and M2-receptor expression raise the possibility that improvement of the cardiac cholinergic system is involved in adenine sulfate–induced cardioprotective effects.
収録刊行物
-
- Journal of Pharmacological Sciences
-
Journal of Pharmacological Sciences 115 (2), 205-213, 2011
公益社団法人 日本薬理学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001205180492672
-
- NII論文ID
- 10029892143
-
- NII書誌ID
- AA11806667
-
- ISSN
- 13478648
- 13478613
-
- NDL書誌ID
- 10979823
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可